找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radionuclide Therapy; Recep Beki?,Berna Polack,Murat Fani Bozkurt Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusi

[復(fù)制鏈接]
樓主: 休耕地
11#
發(fā)表于 2025-3-23 12:08:15 | 只看該作者
Fundamentals of Radiation Safety and Dosimetric Approach in Radionuclide Therapy Applicationsrst used in the local treatment of skin lesions, followed by many new radionuclides [Iodine-131 (I-131), Phosphorus-32 (P-32), Strontium-90 (Sr-90), Samarium-153 (Sm-153)] started to be used in systemic therapy. Recently, several different radiopharmaceuticals such as Gallium-68 (Ga-68) octreotate,
12#
發(fā)表于 2025-3-23 16:51:16 | 只看該作者
Radionuclide Therapy in Benign Thyroid Diseases: Nodular Goiter Diseased can be detected in up to 70% of people on ultrasound examination [1]. The majority of thyroid nodules derive from thyroid follicular cells. Benign follicular nodules, the most common mass lesions, can be single or part of a multinodular goiter. Benign thyroid nodules may tend to increase in size o
13#
發(fā)表于 2025-3-23 21:18:39 | 只看該作者
14#
發(fā)表于 2025-3-23 23:13:40 | 只看該作者
15#
發(fā)表于 2025-3-24 05:21:14 | 只看該作者
16#
發(fā)表于 2025-3-24 08:48:46 | 只看該作者
Radionuclide Therapy in Neuroendocrine Tumorsive epidemiology study conducted by Yao et al. in 2004 by examining the US Surveillance, Epidemiology and End Results records (SEER database), the NET incidence was found to be 5.25/100,000. However, in this study, the rate of increase in the NET incidence was found to be higher than the rate of inc
17#
發(fā)表于 2025-3-24 14:26:29 | 只看該作者
Systemic Treatments and Related Side Effects in Neuroendocrine Tumors, especially gastroenteropancreatic and lung NETs, can be monitored. It may cause local symptoms as well as various clinical conditions based on the hormones it secretes depending on the location [1–3]. Ki-67 index and mitotic index are classified as well-differentiated low grade (grade 1), well-dif
18#
發(fā)表于 2025-3-24 16:26:01 | 只看該作者
Radionuclide Therapy in Neuroectodermal Tumorsfor approximately 30 years, is a targeted internal radiotherapy application which is used in the treatment of metastatic, high-risk neuroectodermal tumors. The objective response in the advanced stage and refractory patient group is between 30% and 40% while the symptomatic response is significant.
19#
發(fā)表于 2025-3-24 19:14:13 | 只看該作者
Systemic Treatments and Related Side Effects in Neuroectodermal Tumorsmbryonic cells, have common biochemical and genetic characteristics, and are usually seen in childhood and young adults. These tumors are rare especially in adults and can be located in the central nervous system (CNS) or can be seen in many organs [1]. CNS-located PNETs were among the embryological
20#
發(fā)表于 2025-3-25 00:35:51 | 只看該作者
Radionuclide Therapy in Liver Tumorson hepatic arterial system in contrast to healthy liver cells that are mostly vascularized from portal venous system. From this point of view, tumor cells can be directly targeted, and healthy liver cells are protected from the possible side effects and complications of high dose radiation to a grea
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 21:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
普兰店市| 始兴县| 万全县| 永平县| 长治县| 榆树市| 昭平县| 和静县| 麟游县| 安龙县| 鄂伦春自治旗| 洛隆县| 贵南县| 泰顺县| 栾川县| 浠水县| 治县。| 米易县| 弥勒县| 大港区| 贺兰县| 大化| 华宁县| 隆昌县| 将乐县| 盘山县| 板桥市| 太保市| 旌德县| 偏关县| 门头沟区| 淳化县| 于田县| 天峨县| 通辽市| 正镶白旗| 余庆县| 定兴县| 吉安县| 资源县| 牟定县|